Key Developments: PDL BioPharma Inc (PDLI.O)
8.22USD
17 May 2013
$0.04 (+0.49%)
$8.18
$8.23
$8.25
$8.18
1,301,816
1,776,528
$8.43
$6.16
Latest Key Developments (Source: Significant Developments)
PDL BioPharma Inc Announces Appointment Of CFO-Form 8-K
PDL BioPharma Inc reported in its Form 8-K that on April 30, 2013, PDL BioPharma, Inc. (the Company) announced its appointment of Peter S. Garcia as Vice President, Chief Financial Officer (CFO) and Acting Chief Accounting Officer, effective May 13, 2013. Mr. Garcia will replace Mr. McLaughlin in his temporary role as Acting Chief Financial Officer and Acting Chief Accounting Officer. Full Article
PDL BioPharma Inc Announces 2013 Regular Quarterly Dividends
PDL BioPharma Inc announced that board of directors has declared that the regular, quarterly dividends to be paid to its stockholders in 2013 will be $0.15 per share of common stock. The $0.15 dividends will each be paid on March 12, June 12, September 12 and December 12 of 2013 to all stockholders who own shares of PDL on March 5, June 5, September 5 and December 5 of 2013, the record dates for each of the dividend payments, respectively. Full Article
PDL BioPharma Inc Issues Q4, FY 2012 Revenue Guidance Above Analysts' Estimates
PDL BioPharma Inc announced that for the fourth quarter of 2012, it expects royalty revenue of approximately $86 million. For fiscal 2012, it expects total revenue to be $374 million. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $79 million for the fourth quarter of 2012; revenue of $368 million for fiscal 2012. Full Article
PDL BioPharma Inc Announces Resignation of Chief Financial Officer
PDL BioPharma Inc announced that Bruce Tomlinson has resigned his position as vice president and Chief Financial Officer(CFO) of PDL due to personal reasons. His resignation is effective as of November 30 , 2012. The Company will begin a search for a new CFO. Full Article
PDL BioPharma Inc Completes Regular Quarterly Dividend Payment
PDL BioPharma Inc announced that it has paid the September 14, 2012, regular quarterly dividend payment of $0.15 per share to all stockholders owning shares of PDL as of September 7, 2012, the record date. Full Article
PDL BioPharma Inc Issues Q3 2012 Revenue Guidance Below Analyst's Estimate
PDL BioPharma Inc announced that for third qaurter 2012 it expects royalty revenue guidance to be approximately $85 million, as compared with actual royalty revenue of $83 million for the third quarter of 2011, a 2% increase. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $88 million for the third quarter of 2012. Full Article
PDL BioPharma Inc To Receive Royalties On Sales Of Genentech's Pertuzumab
PDL BioPharma Inc announced that Genentech has notified PDL that Pertuzumab, brand name Perjeta. PDL will receive royalties on sales of Perjeta in the quarter following the first quarter of Perjeta sales in accordance with Genentech's license agreements with PDL. Full Article
PDL BioPharma Inc Appoints Bruce Tomlinson As Chief Financial Officer
PDL BioPharma Inc announced that the Company has appointed Bruce Tomlinson to the position of Vice President and Chief Financial Officer effective as of June 11, 2012. Full Article
PDL BioPharma Inc Issues Q1 2012 Revenue Guidance Above Analysts' Estimates
PDL BioPharma Inc announced that the total revenue for the first quarter of 2012 is expected to be $6 million less than total revenue for the first quarter of 2011. The Company reported revenue of $83.34 million for the first quarter of 2011. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $73.70 million for the first quarter of 2012. Full Article
PDL BioPharma Inc Announces 2012 Regular Quarterly Dividends
PDL BioPharma Inc announced that its Board of Directors has declared that the regular, quarterly dividends to be paid to its stockholders in 2012 will be $0.15 per share of common stock. The $0.15 dividends will each be paid on March 14, June 14, September 14 and December 14 of 2012 to all stockholders who own shares of PDL on March 7, June 7, September 7 and December 7 of 2012, the record dates for each of the dividend payments, respectively. Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
